About Silicon Biosystems
Silicon Biosystems is a company based in Bologna (Italy) founded in 1999 was acquired by Menarini in September 2013.. Silicon Biosystems has raised $25.53 million across 3 funding rounds from investors including Innogest Capital and Menarini Group. Silicon Biosystems has completed 1 acquisition, including CellSearch. Silicon Biosystems offers products and services including CELLSEARCH, CellMag, and DEPArray. Silicon Biosystems operates in a competitive market with competitors including NanoCellect Biomedical, GenMark Diagnostics, Stilla Technologies, ThinkCyte and Cell Microsystems, among others.
- Headquarter Bologna, Italy
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Menarini Silicon Biosystems Spa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.53 M (USD)
in 3 rounds
-
Latest Funding Round
$15.98 M (USD), Series C
Feb 01, 2010
-
Investors
Innogest Capital
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Menarini
(Sep 12, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Silicon Biosystems
Silicon Biosystems offers a comprehensive portfolio of products and services, including CELLSEARCH, CellMag, and DEPArray. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Test for detecting circulating tumor cells in blood for cancer monitoring.
System for immunomagnetic enrichment of circulating tumor cells.
Technology for single cell isolation and molecular analysis.
Unlock access to complete
Funding Insights of Silicon Biosystems
Silicon Biosystems has successfully raised a total of $25.53M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $15.98 million completed in February 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $16.0M
-
First Round
First Round
(01 Jan 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2010 | Amount | Series C - Silicon Biosystems | Valuation |
investors |
|
| Mar, 2007 | Amount | Series A - Silicon Biosystems | Valuation |
investors |
|
| Jan, 2007 | Amount | Unspecified - Silicon Biosystems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Silicon Biosystems
Silicon Biosystems has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Innogest Capital and Menarini Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm investing in seed and early stage companies in Italy
|
Founded Year | Domain | Location | |
|
Menarini Group is engaged in pharmaceutical and healthcare solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Silicon Biosystems
Silicon Biosystems has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CellSearch. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Circulating tumor cells are detected via specialized blood tests.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Silicon Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Silicon Biosystems Comparisons
Competitors of Silicon Biosystems
Silicon Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, GenMark Diagnostics, Stilla Technologies, ThinkCyte and Cell Microsystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops flow cytometry and cell sorting technology
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Digital PCR solutions for research are developed and analyzed.
|
|
| domain | founded_year | HQ Location |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| domain | founded_year | HQ Location |
Developer of a technology to isolate and recover single cells for molecular analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Silicon Biosystems
Frequently Asked Questions about Silicon Biosystems
When was Silicon Biosystems founded?
Silicon Biosystems was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Where is Silicon Biosystems located?
Silicon Biosystems is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Is Silicon Biosystems a funded company?
Silicon Biosystems is a funded company, having raised a total of $25.53M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $2.72M, raised on Jan 01, 2007.
What does Silicon Biosystems do?
Silicon Biosystems was founded in 1999 in Bologna, Italy, within the biotechnology sector. Lab-on-a-chip solutions are created for cell-biology applications. DNA amplification from single cells is enabled by the Ampli1 whole genome kit. Cells are isolated using DEPArray technology based on dielectrophoresis. An automated DEPArray system is utilized for identifying and recovering rare cells, while Cell Browser software supports image-guided selection of specific cell populations.
Who are the top competitors of Silicon Biosystems?
Silicon Biosystems's top competitors include NanoCellect Biomedical, GenMark Diagnostics and ThinkCyte.
What products or services does Silicon Biosystems offer?
Silicon Biosystems offers CELLSEARCH, CellMag, and DEPArray.
How many acquisitions has Silicon Biosystems made?
Silicon Biosystems has made 1 acquisition, including CellSearch.
Who are Silicon Biosystems's investors?
Silicon Biosystems has 2 investors. Key investors include Innogest Capital, and Menarini Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.